Truc Chi Vu
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Truc Chi Vu.
Tetrahedron Letters | 2002
Wen-Sen Li; Zhenrong Guo; John E. Thornton; Kishta Katipally; Richard Polniaszek; John K. Thottathil; Truc Chi Vu; Michael Wong
Abstract Reduction of 2,6-diacetoxy-2′-bromoacetophenone ( 10 ) with NaBH 4 led to 3,4-diacetoxydihydrobenzofuran ( 12 ) in a process involving acyl migration followed by cyclization. Subsequent hydrogenolysis gave 4-acetoxydihydrobenzofuran which, upon saponification, afforded 4-hydroxydihydrobenzofuran ( 8 ) in good yield. This approach is shown to be a general method for preparation of substituted dihydrobenzofurans.
Tetrahedron | 2000
Stan V. D'Andrea; D P Bonner; Joanne J. Bronson; Junius M. Clark; Ken L. DenBleyker; Joan Fung-Tomc; Shelley E. Hoeft; Thomas W. Hudyma; John D. Matiskella; Raymond F. Miller; Peter F. Misco; Michael J. Pucci; Roman Z. Sterzycki; Yuan Tsai; Yasutsuga Ueda; John A. Wichtowski; Janak Singh; Thomas P. Kissick; Jeffery T. North; Annie Pullockaran; Michael Humora; Brenda T Boyhan; Truc Chi Vu; Alan Fritz; J. Heikes; Rita Fox; Jollie D. Godfrey; Robert Kevin Perrone; Murray Arthur Kaplan; David R. Kronenthal
Abstract Cephalosporin derivatives containing a unique combination of lipophilic C-7 sidechains and polar C-3 thiopyridinium groups were synthesized and found to exhibit potent anti-MRSA activity in vitro and in vivo. The optimum C-7 sidechains utilized were 2,5-dichlorophenylthioacetamido and 2,6-dichloropyrid-4-ylthioacetamido. The C-3 thiopyridinium rings were substituted at nitrogen with amino acid and pyruvic acid groups that were designed to confer aqueous solubility as required for IV formulation. This paper describes the characteristics of these novel cephalosporins and highlights synthetic methods developed to allow their practical, large-scale syntheses.
Archive | 2003
Truc Chi Vu; David B. Brzozowski; Rita Fox; Jollie Duaine Godfrey; Ronald L. Hanson; Sergei V. Kolotuchin; John A. Mazzullo; Ramesh N. Patel; Jianji Wang; Kwok Wong; Jurong Yu; Jason Zhu; David R. Magnin; David J. Augeri; Lawrence G. Hamann
Archive | 2008
Jack Z. Gougoutas; Mary F. Malley; John D. Dimarco; Xiaotian S. Yin; Chenkou Wei; Jurong Yu; Truc Chi Vu; Gregory Scott Jones; Scott A. Savage
Advanced Synthesis & Catalysis | 2007
Ronald L. Hanson; Steven L. Goldberg; David B. Brzozowski; Dana L Cazzulino; William L. Parker; Olav Lyngberg; Truc Chi Vu; Michael K. Wong; Ramesh N. Patel
Organic Process Research & Development | 2009
Scott A. Savage; Gregory Scott Jones; Sergei V. Kolotuchin; Shelly Ann Ramrattan; Truc Chi Vu; Robert E. Waltermire
Archive | 2003
Truc Chi Vu; David B. Brzozowski; Rita Fox; Jollie D. Godfrey; Ronald L. Hanson; Sergei V. Kolotuchin; John A. Mazzullo; Ramesh N. Patel; Jianji Wang; Kwok Wong; Jurong Yu; Jason Zhu; David R. Magnin; David J. Augeri; Lawrence G. Hamann
Organic Process Research & Development | 2001
Animesh Goswami; Jeffrey M. Howell; Edward Y. Hua; K. David Mirfakhrae; Maxime Soumeillant; Shankar Swaminathan; Xinhua Qian; Fernando Quiroz; Truc Chi Vu; Xuebao Wang; Bin Zheng; and David R. Kronenthal; Ramesh N. Patel
Organic Process Research & Development | 2003
J. Siva Prasad; Truc Chi Vu; Michael J. Totleben; Gerard Crispino; David Kacsur; Shankar Swaminathan; John E. Thornton; and Alan Fritz; Ambarish K. Singh
Organic Process Research & Development | 1998
Janak Singh; Gregory S. Bisacchi; Saleem Ahmad; Jollie D. Godfrey; Thomas P. Kissick; Toomas Mitt; Octavian R. Kocy; Truc Chi Vu; Chris G. Papaioannou; Michael K. Wong; James E. Heikes; and Robert Zahler; Richard H. Mueller